Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dextropropoxyphene is an opioid analgesic patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anesthetic effects. The drug has been taken off the market in Europe and the United States due to concerns of fatal…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Dextropropoxyphene. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
propoxyphene paracetamol effects drug patients co-proxamol available opioid alcohol also darvon may withdrawal market anesthetic withdrawn overdose depression pain toxicity
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dextropropoxyphene | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dextropropoxyphene | Addiction liability | Low[failed verification] | 1.00 | infobox |
| Dextropropoxyphene | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dextropropoxyphene | ATC code | N02AC04 (WHO) | 1.00 | infobox |
| Dextropropoxyphene | Bioavailability | 40% | 1.00 | infobox |
| Dextropropoxyphene | CAS Number | 469-62-5 Y | 1.00 | infobox |
| Dextropropoxyphene | ChEBI | CHEBI:51173 Y | 1.00 | infobox |
| Dextropropoxyphene | ChEMBL | ChEMBL1213351 Y | 1.00 | infobox |
| Dextropropoxyphene | ChemSpider | 9696 Y | 1.00 | infobox |
| Dextropropoxyphene | CompTox Dashboard (EPA) | DTXSID1023524 | 1.00 | infobox |
| Dextropropoxyphene | Drug class | Opioid | 1.00 | infobox |
| Dextropropoxyphene | DrugBank | DB00647 N | 1.00 | infobox |
| Dextropropoxyphene | ECHA InfoCard | 100.006.747 | 1.00 | infobox |
| Dextropropoxyphene | Elimination half-life | 6–12 hours; 30–36 hours (active metabolite, nordextropropoxyphene) | 1.00 | infobox |
| Dextropropoxyphene | Excretion | Urine (major), breastmilk (minor) | 1.00 | infobox |
| Dextropropoxyphene | Formula | C22H29NO2 | 1.00 | infobox |
| Dextropropoxyphene | IUPHAR/BPS | 7593 | 1.00 | infobox |
| Dextropropoxyphene | KEGG | D07809 Y | 1.00 | infobox |
| Dextropropoxyphene | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Dextropropoxyphene | Legal status | BR: Class A2 (Narcotic drugs) | 1.00 | infobox |
| Dextropropoxyphene | Legal status | CA: Schedule I | 1.00 | infobox |
| Dextropropoxyphene | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Dextropropoxyphene | Legal status | NZ: Withdrawn (illegal) | 1.00 | infobox |
| Dextropropoxyphene | Legal status | UK: Class C | 1.00 | infobox |
| Dextropropoxyphene | Legal status | US: Schedule II and Schedule IV (when in dosage form) | 1.00 | infobox |
| Dextropropoxyphene | License data | US FDA: Propoxyphene | 1.00 | infobox |
| Dextropropoxyphene | MedlinePlus | a682325 | 1.00 | infobox |
| Dextropropoxyphene | Melting point | 75 °C (167 °F) | 1.00 | infobox |
| Dextropropoxyphene | Metabolism | Liver-mediated, CYP3A4-mediated N-demethylation (major), aromatic hydroxylation (minor) and ester hydrolysis (minor) | 1.00 | infobox |
| Dextropropoxyphene | Molar mass | 339.479 g·mol−1 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.